Common Contracts
2 similar Supply Agreement contracts by Exelixis, Inc.
ContractSupply Agreement • May 5th, 2020 • New York
EX-10.4 3 exel20160331exhibit104-ame.htm EXHIBIT 10.4 CONFIDENTIAL EXHIBIT 10.4 EXECUTION VERSION [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. SUPPLY AGREEMENT This Supply Agreement (the “Supply Agreement”) is entered into as of February 29, 2016 (the “Effective Date”) by and between Exelixis, Inc., a Delaware company having an address at 210 East Grand Avenue, South San Francisco, CA 94080, USA (“Exelixis”), and Ipsen Pharma SAS, a French corporation having an address at 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France (“Licensee”). Exelixis and Licensee may be referred to herein individually as a “Party” and collectively as the “Parties.” RECITALS Whereas, Exelixis, a biopharmaceutical company, is developing its proprietary compound known as cabozantinib for the treatment of ca
SUPPLY AGREEMENTSupply Agreement • September 30th, 2016 • Exelixis, Inc. • Services-commercial physical & biological research • New York
This Supply Agreement (the “Supply Agreement”) is entered into as of February 29, 2016 (the “Effective Date”) by and between Exelixis, Inc., a Delaware company having an address at 210 East Grand Avenue, South San Francisco, CA 94080, USA (“Exelixis”), and Ipsen Pharma SAS, a French corporation having an address at 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France (“Licensee”). Exelixis and Licensee may be referred to herein individually as a “Party” and collectively as the “Parties.”
